Overbrook Management Corp Has $23.89 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Overbrook Management Corp cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,377 shares of the healthcare conglomerate’s stock after selling 531 shares during the period. UnitedHealth Group makes up approximately 4.8% of Overbrook Management Corp’s investment portfolio, making the stock its 5th largest holding. Overbrook Management Corp’s holdings in UnitedHealth Group were worth $23,890,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Iron Horse Wealth Management LLC raised its stake in UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after buying an additional 19 shares during the period. Secure Asset Management LLC raised its stake in UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after buying an additional 19 shares during the period. Bensler LLC raised its stake in UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after buying an additional 19 shares during the period. Texas Capital Bancshares Inc TX raised its stake in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares during the period. Finally, Tealwood Asset Management Inc. increased its stake in shares of UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Barclays increased their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, TD Cowen reduced their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $6.58 during midday trading on Thursday, reaching $493.88. The company’s stock had a trading volume of 4,329,383 shares, compared to its average volume of 4,530,458. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The stock has a market capitalization of $454.41 billion, a P/E ratio of 30.19, a PEG ratio of 1.41 and a beta of 0.54. The firm has a 50 day moving average price of $486.36 and a 200-day moving average price of $514.42. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.26 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s payout ratio is 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.